GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The signaling of glycogen synthase kinase-3β (GSK-3β) has been implicated in stress-induced apoptosis. However, the pro-apoptotic role of GSK-3β is still unclear. Here, we show the involvement of GSK-3β in ceramide-induced mitochondrial apoptosis. Ceramide induced GSK-3β activation via protein dephosphorylation at serine 9. We previously reported that ceramide induced caspase-2 and caspase-8 activation, Bid cleavage, mitochondrial damage, and apoptosis. In this study, we found that caspase-2 activation and the subsequent apoptotic events were abolished by the GSK-3β inhibitors lithium chloride and SB216763, and by GSK-3β knockdown using short interfering RNA. We also found that ceramide-activated protein phosphatase 2A (PP2A) indirectly caused GSK-3β activation, and that the PP2A-regulated PI 3-kinase-Akt pathway was involved in GSK-3β activation. These results indicate a role for GSK-3β in ceramide-induced apoptosis, in which GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 and caspase-8.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 4×
“PP2A activates GSK-3 via PI 3-kinase-Akt signaling Because PI 3-kinase-Akt and MEK/ERK have been implicated in GSK-3 phosphorylation (Cross et al., 1995; Pap and Cooper, 1998; Pap and Cooper, 2002; Hetman et al., 2002), we investigated the effect of PP2A on these signaling pathways.”
BackgroundInfluentialGSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881 · cited 1×
“Recent studies (Letai, 2006; Maurer et al., 2006) have shown that GSK-3 -regulated destabilization of Mcl-1, an anti-apoptotic Bcl-2 family member, was involved in the permeabilization of the mitochondrium outer membrane and in apoptosis.”
BackgroundChavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · cited 3×
“This is consistent with a previous report (Stoica et al., 2003), showing that the dephosphorylation of Akt and GSK3 is associated with ceramide-induced neuronal apoptosis.”
BackgroundERK1/2 Antagonizes Glycogen Synthase Kinase-3β-induced Apoptosis in Cortical Neurons
Hetman, M., Hsuan, S.-L., Habas, A., Higgins, M. J., & Xia, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111227200 · Cited by 88
Cited by
Ceramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
GSK-3 and tau: a key duet in Alzheimer’s disease
Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314
“GSK-3 can also be activated by serine dephosphorylation by phosphatases such as PP2A [29].”
BackgroundReview of Lithium Effects on Brain and Blood
Young, W. (2009) · Cell Transplantation · doi:10.3727/096368909x471251 · Cited by 287
The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family
Heath-Engel, H. M., Chang, N. C., & Shore, G. C. (2008) · Oncogene · doi:10.1038/onc.2008.309 · Cited by 264
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244
Kapfhamer, D., Berger, K. H., Hopf, F. W., Seif, T., Kharazia, V., Bonci, A., & Heberlein, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1292-10.2010 · Cited by 71
“…by the upstream signaling molecules, protein phosphatase 2A (PP2A) and protein kinase B (also called AKT) (Cross et al., 1995; Ivaska et al., 2002; Lin et al., 2007); GSK3 is also a direct target of inhibition by lithium (Klein and Melton, 1996), one of the most widely prescribed drugs for the…”
BackgroundLiu, L., & Eisenman, R. N. (2012) · Genes & Cancer · doi:10.1177/1947601912448067 · Cited by 47
“A common element in numerous PP2A-B56–regulated pathways is GSK3β, whose inhibitory phosphorylation at S9 by AKT/PKB is reversed by PP2A-B56 phosphatase activity.(26,39,40,49,59) We have found that induction of Myc in several cell types (including B lymphoid cells, epithelial cells, and rat and human fibroblasts) corr…”
BackgroundMuscle‐specific Perilipin2 down‐regulation affects lipid metabolism and induces myofiber hypertrophy
Conte, M., Armani, A., Conte, G., Serra, A., Franceschi, C., Mele, M., Sandri, M., & Salvioli, S. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12355 · Cited by 30
Metadata
- Authors
- Lin, C.-F., Chen, C.-L., Chiang, C.-W., Jan, M.-S., Huang, W.-C., & Lin, Y.-S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2007-08-15
- Volume
- 120
- Issue
- 16
- Pages
- 2935-2943
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2096186886
- Cited by
- 140
- References
- 5
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.